Jci_page_head_homepage_01 Jci_page_head_homepage_02
Wen-Chien Chou, Anita L. Hawkins, John F. Barrett, Constance A. Griffin, Chi V. Dang
Published in Volume 108, Issue 10
J Clin Invest. 2001; 108(10):1541–1547 doi:10.1172/JCI14064
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Arsenic specifically suppresses hTERT mRNA levels independent of cell type. The expression of hTERT and c-myc was measured by real-time PCR and normalized to actin in b and human phosphoprotein in a, c, and d. hTERT mRNA levels are expressed as percent of untreated control. (a) Arsenic diminished hTERT mRNA expression in a dose-dependent fashion. Experiments were performed after 12 days of arsenic exposure. (b) Two days of arsenic (0.75 μM) but not vincristine (Vin; 0.075 nM) or doxorubicin (Dox; 50 nM) diminishes hTERT mRNA levels. (c) Cell lines other than NB4 also had decreased hTERT mRNA levels after arsenic treatment. NB4 cells were especially sensitive as 0.75 μM for 8 days had resulted in more than 98% inhibition of hTERT expression. The other cell lines were treated with 2 μM arsenic for 14 days. (d) c-myc expression was also decreased in all four cell lines with arsenic exposure.